Location History:
- Cheshire, GB (2015 - 2016)
- Macclesfield, GB (2014 - 2021)
Company Filing History:
2 out of 26 
1 out of 1,500 
2 out of 832,891 Years Active: 2014-2021
Title: Alistair John Boyd: Innovator in Pharmaceutical Chemistry
Introduction
Alistair John Boyd, based in Macclesfield, GB, is an accomplished inventor with a strong focus on the pharmaceutical sector. He holds a total of five patents, showcasing his innovative spirit and contributions to chemical processes, particularly in the development of pharmaceutical compounds.
Latest Patents
Among his latest patents, Boyd has developed a process for the preparation of osimertinib (AZD9291) and its salt forms. This invention highlights an improved chemical process for manufacturing a compound that serves as a late-stage chemical intermediate in the production of osimertinib and its pharmaceutically acceptable salts. Additionally, he has patented processes for preparing heterocyclic compounds, including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and its salts, which relate to compounds and processes that advance the field of pharmaceutical chemistry.
Career Highlights
Throughout his career, Boyd has contributed significantly to leading companies, such as Forest Laboratories Holdings Limited. His work has focused on innovative solutions in pharmaceutical manufacturing, which have the potential to improve drug production processes and streamline the development of essential medications.
Collaborations
Alistair John Boyd has had the opportunity to collaborate with talented individuals such as Alexander Telford and Melanie Simone Ronsheim. These collaborations have likely enhanced his research capabilities and allowed for the exchange of innovative ideas, further driving advancements in the field.
Conclusion
Alistair John Boyd stands out as a prominent inventor within the pharmaceutical industry. His five patents reflect a commitment to enhancing chemical processes, ultimately contributing to more efficient means of producing vital pharmaceutical compounds. His collaborative efforts and innovative mindset solidify his position as a key player in the realm of pharmaceutical chemistry.